Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,875 | 221 | 69.4% |
| Travel and Lodging | $2,729 | 16 | 27.6% |
| Education | $295.54 | 15 | 3.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $4,282 | 68 | $0 (2024) |
| Mozarc Medical US LLC | $1,498 | 10 | $0 (2024) |
| Bard Peripheral Vascular, Inc. | $508.57 | 8 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $465.94 | 21 | $0 (2024) |
| Travere Therapeutics, Inc. | $453.07 | 17 | $0 (2024) |
| Amgen Inc. | $309.01 | 11 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $267.90 | 9 | $0 (2022) |
| Horizon Therapeutics plc | $258.21 | 13 | $0 (2023) |
| Mallinckrodt Hospital Products Inc. | $219.81 | 8 | $0 (2024) |
| Boston Scientific Corporation | $204.35 | 12 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,092 | 61 | Mozarc Medical US LLC ($1,498) |
| 2023 | $2,599 | 55 | Medtronic, Inc. ($2,149) |
| 2022 | $1,095 | 36 | Medtronic, Inc. ($419.11) |
| 2021 | $1,386 | 36 | Medtronic, Inc. ($1,059) |
| 2020 | $475.79 | 18 | AstraZeneca Pharmaceuticals LP ($136.55) |
| 2019 | $344.76 | 19 | Otsuka America Pharmaceutical, Inc. ($108.48) |
| 2018 | $451.82 | 16 | Keryx Biopharmaceuticals, Inc. ($180.33) |
| 2017 | $455.31 | 11 | Bard Peripheral Vascular, Inc. ($344.09) |
All Payment Transactions
252 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Cardio-renal | ||||||
| 11/19/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/19/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/07/2024 | Ethicon US, LLC | EVARREST (Biological), ETHICON | Food and Beverage | In-kind items and services | $28.88 | General |
| Category: Biosurgical | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/17/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $99.28 | General |
| 10/09/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/08/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $26.32 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/07/2024 | Medtronic, Inc. | ELLIPSYS VASCULAR ACCESS SYSTEM (Device) | Food and Beverage | In-kind items and services | $9.09 | General |
| Category: Catheters | ||||||
| 10/04/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: IMMUNOLOGY | ||||||
| 10/02/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $15.07 | General |
| 09/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Cardio-renal | ||||||
| 09/05/2024 | Medtronic, Inc. | ELLIPSYS VASCULAR ACCESS SYSTEM (Device) | Food and Beverage | In-kind items and services | $5.88 | General |
| Category: Catheters | ||||||
| 09/04/2024 | Medtronic, Inc. | ELLIPSYS VASCULAR ACCESS SYSTEM (Device) | Food and Beverage | In-kind items and services | $50.96 | General |
| Category: Catheters | ||||||
| 09/04/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $16.77 | General |
| 08/29/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $26.04 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/28/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $148.40 | General |
| 08/27/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $17.80 | General |
| 08/06/2024 | Medtronic, Inc. | ELLIPSYS VASCULAR ACCESS SYSTEM (Device) | Food and Beverage | In-kind items and services | $104.79 | General |
| Category: Catheters | ||||||
| 08/06/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: Phosphate binder for ESRD | ||||||
| 07/25/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $17.87 | General |
| 07/24/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $28.33 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/26/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $17.99 | General |
| 06/26/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $2.38 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 873 | 1,872 | $428,130 | $206,503 |
| 2022 | 18 | 973 | 2,023 | $471,438 | $216,930 |
| 2021 | 17 | 1,013 | 2,138 | $517,728 | $244,504 |
| 2020 | 25 | 1,359 | 2,816 | $702,222 | $302,361 |
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 43 | 256 | $192,000 | $66,947 | 34.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 155 | 415 | $53,328 | $36,268 | 68.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 169 | 525 | $46,452 | $30,816 | 66.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 173 | 186 | $38,624 | $23,893 | 61.9% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 30 | 66 | $39,600 | $14,257 | 36.0% |
| 36902 | Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | Facility | 2023 | 47 | 62 | $16,698 | $10,149 | 60.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 31 | 54 | $10,013 | $6,183 | 61.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 14 | 27 | $6,780 | $4,294 | 63.3% |
| 36901 | Insertion of needle and/or tube into hemodialysis circuit with review by radiologist | Facility | 2023 | 34 | 38 | $7,192 | $4,035 | 56.1% |
| 93985 | Complete ultrasound of artery and vein blood flow pre-op assessment on both sides of body for hemodialysis access | Office | 2023 | 21 | 21 | $7,350 | $3,631 | 49.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 30 | 37 | $4,938 | $3,049 | 61.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 16 | 23 | $2,185 | $1,031 | 47.2% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 64 | 89 | $1,263 | $797.94 | 63.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 21 | 21 | $1,115 | $767.22 | 68.8% |
| 99153 | Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | Facility | 2023 | 25 | 52 | $590.76 | $384.79 | 65.1% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 59 | 242 | $181,500 | $64,045 | 35.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 144 | 389 | $46,445 | $29,436 | 63.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 176 | 494 | $41,024 | $25,744 | 62.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 159 | 179 | $41,442 | $25,332 | 61.1% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 12 | 74 | $55,500 | $16,463 | 29.7% |
| 36902 | Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | Facility | 2022 | 65 | 92 | $25,436 | $15,501 | 60.9% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 35 | 56 | $33,600 | $11,736 | 34.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 30 | 55 | $9,393 | $6,895 | 73.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 50 | 62 | $7,162 | $4,923 | 68.7% |
| 36901 | Insertion of needle and/or tube into hemodialysis circuit with review by radiologist | Facility | 2022 | 34 | 37 | $7,174 | $4,377 | 61.0% |
About Dr. Michael Gersch, MD
Dr. Michael Gersch, MD is a Nephrology healthcare provider based in Hot Springs, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1326068867.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Gersch, MD has received a total of $9,900 in payments from pharmaceutical and medical device companies, with $3,092 received in 2024. These payments were reported across 252 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($6,875).
As a Medicare-enrolled provider, Gersch has provided services to 4,218 Medicare beneficiaries, totaling 8,849 services with total Medicare billing of $970,297. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Hot Springs, AR
- Active Since 07/20/2006
- Last Updated 01/15/2020
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1326068867
Products in Payments
- ELLIPSYS VASCULAR ACCESS SYSTEM (Device) $3,202
- ARGYLE (Device) $1,498
- Ellipsys (Device) $935.65
- KRYSTEXXA (Biological) $356.18
- LOKELMA (Drug) $324.65
- Auryxia (Drug) $242.50
- ACTHAR (Biological) $219.81
- BPV-Lutonix (Device) $217.18
- JYNARQUE (Drug) $190.76
- Veltassa (Drug) $178.21
- IBSRELA (Drug) $163.13
- Kerendia (Drug) $155.77
- Tavneos (Drug) $139.36
- BPV-Fluency (Device) $126.91
- BENLYSTA (Biological) $125.08
- Velphoro (Drug) $119.97
- ClosureFast (Device) $94.36
- LUPKYNIS (Drug) $87.21
- SAMSCA (Drug) $77.14
- AURYXIA (Drug) $68.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Hot Springs
Dr. David Desoto, M.d, M.D
Nephrology — Payments: $2,315
Donna Mcghee, Rnp, RNP
Nephrology — Payments: $2,308
Dr. Naveen Trehan, Md, MD
Nephrology — Payments: $2,141
Dr. Robert Mccrary, M.d, M.D
Nephrology — Payments: $905.44
Quratulain Shabbir, M.d, M.D
Nephrology — Payments: $465.38
Dr. John Smith, M.d, M.D
Nephrology — Payments: $366.58